Results from CRIB study on CIMZIA® (certolizumab pegol) demonstrate minimal to no placental transfer of drug from mother to infant during third trimester of pregnancy
New UCB data demonstrates scientific innovation for immunology patients with high unmet needs at the Annual European Congress of Rheumatology (EULAR) 2017
